The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change+6.5% to $124.00
Predicted High$124.00at 6 months
Predicted Low$105.00at 2 months
Max Drawdown (predicted)-9.8%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Jul 31, 2026 2:08 am
Bull
CVLT trends higher to
$124.00
(+6.5% from $116.42)
by Jan 2027.
dip-then-recover
ThesisPost-earnings guidance shock just cut CVLT 20% and the compounder narrative is bruised, so the near-term drifts lower toward the value zone before quality reasserts and the stock grinds back toward the DCF anchor over months.
Invalidated ifA break below $92 on volume without stabilization, or a second guide-down, invalidates the recovery leg.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $116.42 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Jul 31, 2026
—
$116.42at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Aug 14, 2026
$103.00–$129.84typical range · internal point $112.50
—
±11.5%
6/10
post-shock drift as downgrades and estimate cuts continue
What actually happened:
closed $151.10
on Aug 13, 2026 = +29.8% vs the call
(predicted -3.4%)
· direction MISS
(called flat, was up)
· off by 33.2 pp
· accuracy 2/10
· typical range ±11.5%:
OUTSIDE the band
· S&P +4.1%
over the same window — lagged it
1 month
Aug 31, 2026
$96.97–$135.87typical range · internal point $108.00
—
±16.7%
6/10
sentiment overhang meets composite fair value gravity
2 months
Oct 1, 2026
$105.00
—
-9.8%
5/10
basing near fair value, low-beta buyers step in
3 months
Oct 31, 2026
$110.00
—
-5.5%
5/10
quality lens reasserts, next print approaches
4 months
Dec 1, 2026
$116.00
—
-0.4%
4/10
beat streak plus guide reset rebuilds confidence
5 months
Dec 31, 2026
$120.00
—
+3.1%
4/10
year-end mean reversion toward DCF anchor
6 months
Jan 31, 2027
$124.00
—
+6.5%
3/10
converges near deterministic baseline as narrative heals
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$124.22
(+6.7%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.